How Blood-Based Biofluid Testing Is Revolutionizing Cancer Diagnostics
Sep 27, 2024•19 min•Ep. 27
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
In this edition of Clinical Lab Chat, Director of Business Intelligence Chris Wolski discusses with Courtney Noah, PhD, VP of Scientific Affairs at BioIVT, how blood-based biofluid testing is poised to revolutionize cancer diagnostics.
Among the topics they dig into are:
- The benefits of blood-based biofluid testing over traditional, more invasive methods.
- How biofluid testing saves money and improves access for patients.
- How labs can add blood-based biofluid testing onto their diagnostic menus.
- The importance of proper sample collection.
- The renaissance in the use of blood-based biomarkers in diagnostic testing.
For the best experience, listen in Metacast app for iOS or Android